Lindbrook Capital, LLC Nuvation Bio Inc. Transaction History

Lindbrook Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$1.56 - $1.84 $1,212 - $1,429	777 Added 473.78%	941 $1,000
Q1 2023 Apr 26, 2023	SELL	$1.6 - $2.48 $4,352 - $6,745	-2,720 Reduced 94.31%	164 $0
Q4 2022 Jan 24, 2023	BUY	$1.68 - $2.5 $3,449 - $5,132	2,053 Added 247.05%	2,884 $0
Q3 2022 Nov 10, 2022	BUY	$0.29 - $4.04 $240 - $3,357	831 New	831 $2,000

152

123M

9.7K

6.5K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $480M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.